Table 3 Case fatality rate of presumed toxoplasma encephalitis and associated factors
N | Number of death | % Death of study population | OR (95% CI) | P value | |
|---|---|---|---|---|---|
Age | |||||
<40 | 63 | 22 | 22.7 | 1 | 0.1 |
>40 | 34 | 7 | 7.2 | 0.5 (0.2 – 1.3) | |
Sex | |||||
Female | 51 | 11 | 11.8 | 1 | 0.06 |
Male | 46 | 18 | 18.6 | 2.3 (0.9 – 5.8) | |
Altered sensorium | |||||
No | 74 | 16 | 16.5 | 1 | 0.002 |
Yes | 23 | 13 | 13.4 | 4.7 (1.6 – 13.5) | |
Focal signs | |||||
No | 33 | 4 | 4.1 | 1 | 0.006 |
Yes | 64 | 25 | 25.8 | 4.6 (1.4 – 15.6) | |
Seizures | |||||
No | 41 | 7 | 7.2 | 1 | 0.02 |
Yes | 56 | 22 | 22.7 | 3.1 (1.1 – 8.6) | |
Neck stiffness | |||||
No | 82 | 21 | 21.6 | 1 | 0.03 |
Yes | 15 | 8 | 8.2 | 3.3 (1.1 – 10.2) | |
CD4 cell count | |||||
>100/mm3 | 26 | 3 | 3.1 | 1 | 0.001 |
<100/mm3 | 71 | 26 | 26.8 | 4.4 (1.5 – 16.9) | |
Total | 97 | 29 | 29.9 | / | / |